TESTOSTERONE UNDECYLATE
Mesothelioma Peritoneum
Aminex Therapeutics, Inc.Small moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
8 Active assets in the Mesothelioma Peritoneum cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Nivolumab TCR2 Therapeutics | Phase 2 | B |
Ipilimumab TCR2 Therapeutics | Phase 2 | B |
Cyclophosphamide TCR2 Therapeutics | Phase 1/2 | CCC |
Fludarabine TCR2 Therapeutics | Phase 1/2 | CCC |
Eflornithine Aminex Therapeutics, Inc. | Phase 1/2 | CCC |
View all 9 →
Same molecule, other indications
TESTOSTERONE UNDECYLATE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →